[TIMP-2]•[IGFBP7] have been incorporated into the first diagnostic test for AKI approved by the US Food and Drug Administration (FDA)—NephroCheck (Astute Medical, San Diego, CA, USA). Here, TIMP2 is linked to acute kidney injury.